Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

36.15
Delayed Data
As of Aug 03
 +0.09 / +0.25%
Today’s Change
27.51
Today|||52-Week Range
36.46
+16.05%
Year-to-Date
The Zacks Analyst Blog Highlights: Pfizer, DuPont, Procter & Gamble and Hospira - Pre...
Aug 03 / Zacks.com
Pfizer (PFE) Beats on Q2 Earnings and Revenues - Tale of the Tape
Jul 28 / Zacks.com
Allergan is Cramer's Favorite Stock, Teva Deal Was 'Incredible'
Aug 01 / TheStreet.com
Today's Pre-Market Trading Very Positive For Pfizer (PFE)
Jul 28 / TheStreet.com
Dow Jones (DJIA) Today: Pfizer (PFE) Higher
Jul 31 / TheStreet.com
Pfizer Beats Q2 Views
Jul 28 / Benzinga
3 Things You Likely Missed in Pfizer's Q2 Report
Jul 31 / MotleyFool.com
Futures Soar On Hope Central Planners Are Back In Control, China Rollercoaster Ends I...
Jul 28 / Investing Channel
Dow 30 Stock Roundup: Pfizer, P&G, Merck Beat on Earnings, DuPont Misses Estimates - ...
Jul 31 / Zacks.com
Are These 2 Big Pharmas Really Buyout Candidates?
Jul 28 / MotleyFool.com
Dow Jones (DJIA) Today: Pfizer (PFE) Higher
Jul 30 / TheStreet.com
Earnings Scheduled For July 28, 2015
Jul 28 / Benzinga
Price Isn't a Problem for Gilead Sciences
Jul 30 / TheStreet.com
Stocks: 5 things to know before the open
Jul 28 / CNNMoney.com
Price Isn't a Problem for Gilead Sciences
Jul 30 / TheStreet.com
What's in Store for Hospira (HSP) this Earnings Season? - Analyst Blog
Jul 27 / Zacks.com
AstraZeneca beats earnings expectations in spite of strong dollar
Jul 30 / FT.com
Will Currency & Generics Weigh on Pfizer (PFE) Q2 Earnings? - Analyst Blog
Jul 27 / Zacks.com
Hospira (HSP) Beats on Q2 Earnings Driven by Strong Sales - Analyst Blog
Jul 29 / Zacks.com
Will Headwinds Weigh on Glaxo's (GSK) Earnings in Q2? - Analyst Blog
Jul 27 / Zacks.com
Pharmaceuticals: Prescribing pain
Jul 29 / FT.com
Allergan signals appetite for new mega deal after $41bn disposal
Jul 27 / FT.com
Bull Chart of the Day -- Pfizer Remains Healthy
Jul 29 / TheStreet.com
Norfolk Southern, Roper Industries, Pfizer, Merck and IBM are part of Zacks Earnings ...
Jul 27 / Zacks.com
Big Pharma seeks recreational drug users for clinical trials
Jul 29 / FT.com
3 Questions Wall Street Wants Answered When Pfizer Reports Q2 Results
Jul 27 / MotleyFool.com
Dow Jones (DJIA) Today: Pfizer (PFE) Higher
Jul 29 / TheStreet.com
Allergan sells generic drugs unit to Teva for $40bn
Jul 27 / FT.com
Bull Chart of the Day: Pfizer
Jul 29 / TheStreet.com
Companies diary: July 27 - July 31
Jul 26 / FT.com
Stock Market News for July 29, 2015 - Market News
Jul 29 / Zacks.com
Earnings Growth Hard to Come By - Earnings Preview
Jul 24 / Zacks.com
Violent Government Buying Spree Sends Chinese Stocks Soaring At Close Of Trading; Yel...
Jul 29 / Investing Channel
Bristol-Myers Beats on Q2 Earnings, Raises 2015 Guidance - Analyst Blog
Jul 23 / Zacks.com
Pfizer (PFE) Earnings Report: Q2 2015 Conference Call Transcript
Jul 28 / TheStreet.com
Zacks Industry Outlook Highlights: AbbVie, Allergan, Pfizer, Juno and Johnson & Johns...
Jul 22 / Zacks.com
Stocks Rebound Sharply, Helped by Higher Oil Prices
Jul 28 / TheStreet.com
2015bs Top 6 Big Pharma Headlines Thus Far
Jul 22 / MotleyFool.com
Pfizer Beats Estimates On Strong Cancer Drug Sales
Jul 28 / TheStreet.com
Companies rush to sell debt before August
Jul 22 / FT.com
3 Stocks Advancing The Drugs Industry
Jul 28 / TheStreet.com
Amgen and Sanofi to battle for cholesterol-busting crown
Jul 22 / FT.com
Pfizer CEO has 'sufficient courage' to pursue deals
Jul 28 / FT.com
Pharma Stock Outlook - July 2015 - Zacks Analyst Interviews
Jul 21 / Zacks.com
China, the Fed Coming to Grips - Ahead of Wall Street
Jul 28 / Zacks.com
Pharma Stock Outlook - July 2015 - Industry Outlook
Jul 21 / Zacks.com
Pfizer Beats on Q2 Earnings and Revenues, Revises Outlook - Analyst Blog
Jul 28 / Zacks.com
Pharmaceuticals: Brain power
Jul 19 / FT.com
Pfizer (PFE) Stock Climbs on Strong Earnings
Jul 28 / TheStreet.com
Pfizer ranked top foreign research partner for UK academics
Jul 19 / FT.com